These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
19. Ledipasvir + sofosbuvir (Harvoni). A therapeutic advance in genotype 1 hepatitis C virus infection, despite uncertainties. Prescrire Int; 2015 Dec; 24(166):285-9. PubMed ID: 26788571 [Abstract] [Full Text] [Related]
20. Efficacy of ledipasvir and sofosbuvir, with or without ribavirin, for 12 weeks in patients with HCV genotype 3 or 6 infection. Gane EJ, Hyland RH, An D, Svarovskaia E, Pang PS, Brainard D, Stedman CA. Gastroenterology; 2015 Nov; 149(6):1454-1461.e1. PubMed ID: 26261007 [Abstract] [Full Text] [Related] Page: [Next] [New Search]